DiaMedica Therapeutics (DMAC) Long-Term Investments (2023 - 2025)
DiaMedica Therapeutics' (DMAC) quarterly Long-Term Investments came in at $1.0 million in Q1 2025, down 89.74% quarter-over-quarter from $9.7 million in Q3 2023.
DiaMedica Therapeutics (DMAC) Long-Term Investments (2023 - 2025) Analysis & Trends
DiaMedica Therapeutics' Long-Term Investments history runs 2 years deep, the most recent figure standing at $1.0 million for Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 505,194.89 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | DiaMedica Therapeutics | 364.72 Mn | 364.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.00 Mn |
| Sep 30, 2023 | 9.75 Mn |
| Jun 30, 2023 | 20.30 Mn |